CAM
TECH icon

Claret Asset Management’s Bio-Techne TECH Stock Holding History

Claret Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$231K Buy
4,415
+1
+0% +$60 0.03% 283
2025
Q4 		$260K Sell
4,414
-10
-0.2% -$608 0.03% 236
2025
Q3 		$246K Sell
4,424
-63
-1% -$3.38K 0.03% 269
2025
Q2 		$231K Buy
+4,487
New +$225K 0.03% 395
2024
Q4 		– Sell
-2,556
Closed -$204K – 348
2024
Q3 		$204K Buy
+2,556
New +$192K 0.03% 311

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Claret Asset Management's TECH Position: Q1 2026 in Review

Claret Asset Management increased its Bio-Techne (TECH) stake by 0.02% in Q1 2026, buying an estimated $60 and bringing the position to 4,415 shares worth $231K. The position accounts for 0.03% of the portfolio, ranked #283.

Claret Asset Management first reported a position in TECH in Q3 2024 and has held it in 5 quarters since. The position peaked at $260K in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Claret Asset Management held 4,415 shares of Bio-Techne worth $231K as of Q1 2026.
  • Claret Asset Management bought 1 Bio-Techne share in Q1 2026, an estimated $60.
  • Bio-Techne made up 0.03% of Claret Asset Management's portfolio in Q1 2026, its #283 holding.
  • Claret Asset Management first reported a position in Bio-Techne in Q3 2024 and has held it in 5 quarters since.
  • Claret Asset Management's Bio-Techne position peaked at $260K in Q4 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.